Global X-ray Market Driven by Increasing Demand from

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Global X-ray Market Driven by Increasing Demand from Emerging Countries, to Exhibit 4.5% CAGR from 2022

Albany - New York, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) has announced the release of a new market study in its catalog of healthcare industry reports. The report examines the historical performance of the global X-ray market and provides forecasts for various segments of the market. The report is titled ‘X-ray Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022’ and is available for sale on the official website of TMR.

X-rays are an invisible part of the electromagnetic spectrum and can be used for diagnostic purposes due to the property of bones of being impermeable to X-rays. This allows medical practitioners to obtain detailed images of the internal structure of various parts of the body, aiding easy diagnosis and effective treatment. According to the report, the global X-ray market was valued at US$7.9 bn in 2013. Exhibiting a steady 4.5% CAGR from 2014 to 2022, the market’s valuation is expected to rise to US$11.8 bn.

Browse Industry Research Report with free Analysis: http://www.transparencymarketresearch.com/x-ray-market.html

The rising prevalence of dental and cardiovascular disorders is the prime factor driving the demand for X-ray diagnostic systems. The increasing prevalence of orthopedic disorders and the benefits of diagnosing them early on with precise X-ray systems have also driven the global X-ray market.

The increasing global geriatric population is another major driver for the global X-ray market, as the geriatric demographic is more prone to both orthopedic and dental disorders than younger demographics.

The technological advancements in X-ray systems and the growing incorporation of modern devices and techniques has also made consumers more comfortable with X-ray technology. This is another major driver for the global X-ray market.

However, the high costs of advanced diagnostic tools have held the X-ray market back in emerging regions. The increasing prevalence of socialized or universal healthcare programs is also leading to an effort to cut costs, which has kept the demand for advanced X-ray systems in check.

Get Research PDF for more Professional and Technical Insights: http://www.transparencymarketresearch.com/sam...rep_id=194

By type of usage, stationary X-ray systems held a dominant 60.1% share in the global X-ray market in 2013. Stationary X-ray systems have been used since the introduction of X-ray technology to medical science due to their convenience and low level of technical intricacy. However, the demand for portable and handheld X-ray systems is growing rapidly – to the extent that mobile and handheld X-ray systems are expected to become the major product type in the global X-ray market by 2022. Portable X-ray systems eliminate the need for any effort on the part of the patient, as the equipment can even be used by the bedside. Considering the serious nature of ailments for which X-ray systems are used for diagnosis, this represents a significant advancement.

By technology, digital X-ray systems overtook the conventional analog X-ray systems in the last few decades and now hold a dominant 69.1% of the global X-ray market. Within digital X-ray systems, computed radiography held the largest market share in 2013.

Regionally, the Asia Pacific market for X-ray systems is expected to exhibit the highest growth rate in the 2014-2022 forecast period, driven by the increasing demand from China and India. However, North America was the largest regional segment of the global X-ray market in 2013, accounting for 34.6% of the global market.

Major players in the global X-ray market include Fujifilm Holdings Corporation, Carestream Health Inc., GE Healthcare, Canon Inc., Hologic Inc., Shimadzu Corporation, Hitachi Medical Corporation, Siemens Healthcare, PerkinElmer, Inc., and Toshiba Corporation.

Browse Press Release on Global X-ray Market: http://www.transparencymarketresearch.com/pre...market.htm

The global X-ray market is segmented as follows:

Global X-ray Market, by Product Type

  • Stationary X-ray
  • Portable X-ray

Global X-ray Market, by Technology

  • Analog X-ray
  • Digital X-ray

Global X-ray Detectors Market, by Type

  • Photostimulable Storage Phosphor (PSP) Detectors
  • Flat Panel Detectors
  • Other X-ray Detectors (CCD, CMOS, X-ray Films, etc.)

Global X-ray Market, by Applications

  • Cardiovascular
  • Respiratory
  • Dental
  • Mammography
  • Others (Abdominal, Orthopedic, etc.)

Global X-ray Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Africa
  • Rest of the World (RoW)

Browse Other Research Reports:

About Us:

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us: Rohit Bhisey Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles